Last reviewed · How we verify

NCT05807763: PEHFLIP

Fundoplication in Laparoscopic PEH Repair Based on FLIP

ENROLLING BY INVITATION NA Last updated 27 November 2024
What this trial tests

NA trial testing Laparoscopic paraesophageal hernia repair without fundoplication in Paraesophageal Hernia in 260 participants. Enrolling by invitation.

Timeline
22 February 2023
Primary endpoint
22 February 2025
22 February 2029

Quick facts

Lead sponsorThe Foundation for Surgical Innovation and Education
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment260
Start date22 February 2023
Primary completion22 February 2025
Estimated completion22 February 2029
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

The Foundation for Surgical Innovation and Education

Who can join

18 and older, any sex, with Paraesophageal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective randomized controlled trial to identify a sub-set of patients that do not benefit from the routine addition, and added morbidity, of a fundoplication during laparoscopic paraesophageal hernia repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Paraesophageal Hernia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05807763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing